SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-06-000052
Filing Date
2006-08-30
Accepted
2006-08-30 16:23:48
Documents
3
Period of Report
2006-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 8K CEO AND CHAIRMAN CHANGES dorceochairmanchange.htm 8-K 27592
2 SCHABER EMPLOYMENT AGREEMENT schaberemploymentagreement.htm EX-10.1 84207
3 DOR PRESSRELEASE ON 8K pressrelease082906.htm EX-99.1 PRESSRELEASE 26629
  Complete submission text file 0000812796-06-000052.txt   140276
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 061065703
SIC: 2834 Pharmaceutical Preparations